Related Experiment Video
Updated: Feb 20, 2026
06:38
Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
Published on: December 8, 2023
1.7K
Bacterial Outer Membrane Vesicles in Potentiating Cancer Vaccines: Progress and Prospects
Jiabeini Zhang1, Tianyu Shao2,3, Fengjiang Qu4
1Department of Breast Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|February 19, 2026
Summary
Bacterial outer membrane vesicles (OMVs) show promise for enhancing cancer vaccines. These versatile platforms can improve immune activation and overcome limitations of current tumor vaccines for better cancer immunotherapy.
Area of Science:
- Immunology
- Biotechnology
- Oncology
Background:
- Cancer immunotherapy is shifting towards personalized strategies, with cancer vaccines as a key approach.
- Current cancer vaccines face challenges like limited clinical responses and low immunogenicity.
- Bacterial outer membrane vesicles (OMVs) offer natural immunomodulatory properties and engineering flexibility for vaccine development.
Purpose of the Study:
- To review recent advances in using OMVs to enhance cancer vaccine effectiveness.
- To explain OMVs' biological features, mechanisms of immune response enhancement, and engineering strategies.
- To discuss challenges and future directions for OMV-based cancer vaccines.
Main Methods:
- Literature review of recent advances in OMV-based cancer vaccines.
- Analysis of OMV biological features and immunomodulatory mechanisms.
- Examination of engineering strategies for OMV safety, immunogenicity, and specificity.
Main Results:
- OMVs possess inherent properties suitable for cancer immunotherapy.
- Engineering strategies can significantly improve OMV safety, immunogenicity, and specificity.
- OMVs represent a promising platform to overcome current cancer vaccine limitations.
Conclusions:
- OMVs are a transformative platform for developing next-generation cancer vaccines.
- Future personalized OMV-based immunotherapies may integrate AI and neoantigen discovery.
- OMVs hold significant potential to advance cancer immunotherapy and overcome treatment obstacles.
Keywords:
bacterial engineeringcancer immunotherapycancer vaccineshybrid membrane vesiclesouter membrane vesiclessurface modificationMore Related Videos
Related Concept Videos
01:30Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
01:29Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
01:03Rous Sarcoma Virus (RSV) and Cancer
6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.5K